Cecilia Kanyama

2.1k total citations
18 papers, 179 citations indexed

About

Cecilia Kanyama is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Cecilia Kanyama has authored 18 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Epidemiology and 5 papers in Emergency Medicine. Recurrent topics in Cecilia Kanyama's work include Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Fungal Infections and Studies (5 papers) and HIV-related health complications and treatments (5 papers). Cecilia Kanyama is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Fungal Infections and Studies (5 papers) and HIV-related health complications and treatments (5 papers). Cecilia Kanyama collaborates with scholars based in Malawi, United States and Zimbabwe. Cecilia Kanyama's co-authors include Mina C. Hosseinipour, Sandra Wagner Cardoso, Thomas Campbell, Amita Gupta, Javier R. Lama, Wadzanai Samaneka, Cynthia Riviere, Patcharaphan Sugandhavesa, Mitch Matoga and Irving Hoffman and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Cecilia Kanyama

17 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cecilia Kanyama Malawi 8 97 81 52 31 29 18 179
Mooketsi Molefi Botswana 9 180 1.9× 195 2.4× 24 0.5× 7 0.2× 15 0.5× 21 262
Patcharaphan Sugandhavesa Thailand 7 28 0.3× 56 0.7× 49 0.9× 34 1.1× 18 0.6× 12 152
Judit Villar-García Spain 9 135 1.4× 19 0.2× 78 1.5× 20 0.6× 71 2.4× 15 298
Alberto Terrón Spain 10 90 0.9× 82 1.0× 41 0.8× 5 0.2× 62 2.1× 21 252
Ana Gómez Spain 10 202 2.1× 142 1.8× 37 0.7× 6 0.2× 14 0.5× 20 257
Ilaria Caramma Italy 10 107 1.1× 129 1.6× 17 0.3× 4 0.1× 92 3.2× 14 245
Gabriella De Girolamo Italy 8 109 1.1× 50 0.6× 92 1.8× 18 0.6× 87 3.0× 12 290
Nardin Rezk United States 4 127 1.3× 23 0.3× 14 0.3× 49 1.6× 59 2.0× 4 212
Simona Coladonato Italy 6 91 0.9× 73 0.9× 44 0.8× 6 0.2× 23 0.8× 11 202
M Volpicelli Italy 7 37 0.4× 37 0.5× 20 0.4× 135 4.4× 6 0.2× 10 349

Countries citing papers authored by Cecilia Kanyama

Since Specialization
Citations

This map shows the geographic impact of Cecilia Kanyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Kanyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Kanyama more than expected).

Fields of papers citing papers by Cecilia Kanyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Kanyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Kanyama. The network helps show where Cecilia Kanyama may publish in the future.

Co-authorship network of co-authors of Cecilia Kanyama

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Kanyama. A scholar is included among the top collaborators of Cecilia Kanyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Kanyama. Cecilia Kanyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Gatechompol, Sivaporn, Stephen J. Kerr, Sandra Wagner Cardoso, et al.. (2023). Monocyte to lymphocyte ratio and hemoglobin level to predict tuberculosis after antiretroviral therapy initiation. AIDS. 38(1). 31–38. 2 indexed citations
3.
Epeldegui, Marta, Di Chang, Jeannette Y. Lee, et al.. (2023). Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes. 94(2). 165–173. 4 indexed citations
4.
Sephton-Clark, Poppy, Jennifer L. Tenor, Dena L. Toffaletti, et al.. (2022). Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome. mBio. 13(6). e0262622–e0262622. 28 indexed citations
6.
Heller, Tom, et al.. (2022). Implementing Advanced HIV Disease Care for Inpatients in a Referral Hospital in Malawi – Demand, Results and Cost Implications. Annals of Global Health. 88(1). 16–16. 6 indexed citations
7.
Matoga, Mitch, Gregory P. Bisson, Amita Gupta, et al.. (2021). Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy. Clinical Infectious Diseases. 73(4). e870–e877. 1 indexed citations
8.
Adewumi, Moses Olubusuyi, Elena Dukhovlinova, Nathan Y. Shehu, et al.. (2020). HIV-1 Central Nervous System Compartmentalization and Cytokine Interplay in Non-Subtype B HIV-1 Infections in Nigeria and Malawi. AIDS Research and Human Retroviruses. 36(6). 490–500. 7 indexed citations
9.
Kanyama, Cecilia, Síle F. Molloy, Adrienne K Chan, et al.. (2019). One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi. Clinical Infectious Diseases. 70(3). 521–524. 14 indexed citations
10.
Rosenberg, Nora E., et al.. (2018). HIV and early hospital readmission: evaluation of a tertiary medical facility in Lilongwe, Malawi. BMC Health Services Research. 18(1). 225–225. 5 indexed citations
11.
Shivakoti, Rupak, Nikhil Gupte, Srikanth Tripathy, et al.. (2018). Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study. BMC Medicine. 16(1). 161–161. 10 indexed citations
12.
Kanyama, Cecilia, et al.. (2016). Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene. 110(5). 305–311. 15 indexed citations
13.
Shivakoti, Rupak, Parul Christian, Nikhil Gupte, et al.. (2015). Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults. Clinical Nutrition. 35(1). 183–189. 22 indexed citations
14.
Shivakoti, Rupak, Sima Berendes, Cecilia Kanyama, et al.. (2015). Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings. The Journal of Infectious Diseases. 213(7). 1074–1078. 13 indexed citations
15.
Smeaton, Laura, Amita Gupta, Javier R. Lama, et al.. (2015). A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings. Open Forum Infectious Diseases. 2(3). ofv095–ofv095. 22 indexed citations
16.
Vorkas, Charles Kyriakos, et al.. (2015). Altered mental status is an indicator of mortality and associated with both infectious and non-communicable disease in Lilongwe, Malawi. Tropical Doctor. 45(3). 164–167. 3 indexed citations
17.
Shivakoti, Rupak, Nikhil Gupte, Noluthando Mwelase, et al.. (2014). Pre-Antiretroviral Therapy Serum Selenium Concentrations Predict WHO Stages 3, 4 or Death but not Virologic Failure Post-Antiretroviral Therapy. Nutrients. 6(11). 5061–5078. 16 indexed citations
18.
Périssé, André Reynaldo Santos, Laura Smeaton, Yun Chen, et al.. (2013). Outcomes among HIV-1 Infected Individuals First Starting Antiretroviral Therapy with Concurrent Active TB or Other AIDS-Defining Disease. PLoS ONE. 8(12). e83643–e83643. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026